Advertisement

Topics

Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

19:29 EDT 13 Jun 2018 | Investing News Network

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Diflorasone Diacetate Ointment 0.05%. This is Teligent’s fifth approval for 2018, and its twenty-fourth approval from its internally-developed pipeline of topical generic pharmaceutical … Continued

The post Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05% appeared first on Investing News Network.

Original Article: Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

NEXT ARTICLE

More From BioPortfolio on "Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...